Literature DB >> 17303884

When are randomised trials unnecessary? Picking signal from noise.

Paul Glasziou1, Iain Chalmers, Michael Rawlins, Peter McCulloch.   

Abstract

Although randomised trials are widely accepted as the ideal way of obtaining unbiased estimates of treatment effects, some treatments have dramatic effects that are highly unlikely to reflect inadequately controlled biases. We compiled a list of historical examples of such effects and identified the features of convincing inferences about treatment effects from sources other than randomised trials. A unifying principle is the size of the treatment effect (signal) relative to the expected prognosis (noise) of the condition. A treatment effect is inferred most confidently when the signal to noise ratio is large and its timing is rapid compared with the natural course of the condition. For the examples we considered in detail the rate ratio often exceeds 10 and thus is highly unlikely to reflect bias or factors other than a treatment effect. This model may help to reduce controversy about evidence for treatments whose effects are so dramatic that randomised trials are unnecessary.

Mesh:

Year:  2007        PMID: 17303884      PMCID: PMC1800999          DOI: 10.1136/bmj.39070.527986.68

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  15 in total

1.  Case reports in an evidence-based world.

Authors:  J P Vandenbroucke
Journal:  J R Soc Med       Date:  1999-04       Impact factor: 5.344

2.  When are observational studies as credible as randomised trials?

Authors:  Jan P Vandenbroucke
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

3.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

Review 4.  Evaluating non-randomised intervention studies.

Authors:  J J Deeks; J Dinnes; R D'Amico; A J Sowden; C Sakarovitch; F Song; M Petticrew; D G Altman
Journal:  Health Technol Assess       Date:  2003       Impact factor: 4.014

5.  Quality-of-life changes and hearing impairment. A randomized trial.

Authors:  C D Mulrow; C Aguilar; J E Endicott; M R Tuley; R Velez; W S Charlip; M C Rhodes; J A Hill; L A DeNino
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

6.  Pertinency of an extraneous variable.

Authors:  I D Bross
Journal:  J Chronic Dis       Date:  1967-07

7.  Successful use of topical vitamin E solution in the treatment of nail changes in yellow nail syndrome.

Authors:  H C Williams; R Buffham; A du Vivier
Journal:  Arch Dermatol       Date:  1991-07

8.  Multicenter prospective evaluation of laparoscopic antireflux surgery. Preliminary report.

Authors:  A Cuschieri; J Hunter; B Wolfe; L L Swanstrom; W Hutson
Journal:  Surg Endosc       Date:  1993 Nov-Dec       Impact factor: 4.584

9.  The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms.

Authors:  J H Peters; T R DeMeester; P Crookes; S Oberg; M de Vos Shoop; J A Hagen; C G Bremner
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

10.  Symptoms and antireflux medication use following laparoscopic Nissen fundoplication: outcome at 1 and 4 years.

Authors:  Mark Bloomston; William Nields; Alexander S Rosemurgy
Journal:  JSLS       Date:  2003 Jul-Sep       Impact factor: 2.172

View more
  113 in total

Review 1.  Pharmacotherapy options for advanced thyroid cancer: a systematic review.

Authors:  Christian Lerch; Bernd Richter
Journal:  Drugs       Date:  2012-01-01       Impact factor: 9.546

2.  Time for a new approach to case reports.

Authors:  Riaz Agha; R David Rosin
Journal:  Int J Surg Case Rep       Date:  2010-05-04

Review 3.  Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948.

Authors:  Peter D Spain; Nina Kadan-Lottick
Journal:  J R Soc Med       Date:  2012-04       Impact factor: 5.344

4.  Evidence-based mechanistic reasoning.

Authors:  Jeremy Howick; Paul Glasziou; Jeffrey K Aronson
Journal:  J R Soc Med       Date:  2010-11       Impact factor: 5.344

5.  The urge to sprinkle statistics is irresistible.

Authors:  James Penston
Journal:  BMJ       Date:  2007-03-03

6.  Beware the "Texas sharp shooter" in rate ratios of progression.

Authors:  Anna C Goodman
Journal:  BMJ       Date:  2007-03-03

7.  Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.

Authors:  Justin E Bekelman; Nandita Mitra; Jason Efstathiou; Kaijun Liao; Robert Sunderland; Deborah N Yeboa; Katrina Armstrong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-16       Impact factor: 7.038

8.  Observational studies: More than high standards needed.

Authors:  Guy Lloyd
Journal:  BMJ       Date:  2007-11-03

9.  The use of historical controls and concurrent controls to assess the effects of sulphonamides, 1936-1945.

Authors:  Irvine Loudon
Journal:  J R Soc Med       Date:  2008-03       Impact factor: 5.344

10.  Evaluating surgery.

Authors:  Jonathan L Meakins
Journal:  J R Soc Med       Date:  2007-08       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.